Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
166.4 USD | +1.26% | +3.53% | +7.39% |
May. 17 | Cantor Fitzgerald Initiates AbbVie at Overweight Rating With $200 Price Target | MT |
May. 17 | ANALYST RECOMMENDATIONS : Walmart, Netflix, Abbvie, Delta... |
Official Publications
SEC Filing 10Q-1 | CO | |
1st quarter results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
Proxy Statments | CO | |
SEC Filing 10K | CO | |
Annual results | CO | |
SEC Filing 8K | CO | |
SEC Filing 13G | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-3 | CO | |
3rd quarter results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-2 | CO | |
1st-half-year results | CO | |
SEC Filing 8K | CO | |
SEC Filing 4K | CO | |
SEC Filing 8K | CO | |
SEC Filing 4K | CO | |
Shareholders meeting voting results | CO | |
SEC Filing 10Q-1 | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- Official Publications